Release date- 30082019 - The Novo Nordisk Foundation makes large grant to the development of new biopharmaceutical
processes, as well as education and training of students and employees in the industry.
M2 PRESSWIRE-August 15, 2019-: Biopharmaceutical
and Biomedicine Market Dynamics and by Region - Global Industry Insights, and Forecast 2017 to 2025
The market for biopharmaceutical
logistics shall be driven by factors such as logistics providers having local contacts and know-how, innovation in packaging and increased manufacture and use of biologic drugs.
[USPRwire, Mon Apr 22 2019] This report analyzes the global biopharmaceutical
fermentation systems market in terms of its current and future scenario.
- South Korean pharmaceutical company SK Biopharmaceuticals
and US-based artificial intelligence -driven biopharmaceutical
company twoXAR, Inc have inked an agreement to discover and develop first-in-class therapeutics for non-small cell lung cancer (NSCLC), the companies said.
South Korea-based SK Biopharmaceuticals
has collaborated with an artificial intelligence-driven biopharmaceutical
firm, twoXAR, for the discovery and development of products to treat non-small cell lung cancer, it was reported yesterday.
The United States is the largest market for biopharmaceuticals
, accounting for around a third of the global market, and is the world leader in biopharmaceutical
company Arvelle Therapeutics GmbH reported on Wednesday an exclusive licensing agreement to develop and commercialise cenobamate in Europe in partnership with SK Biopharmaceuticals
SGS is investing more than $1.7 million to expand its North American biopharmaceutical
testing capabilities at its Lincolnshire facility near Chicago, IL.
There is a "huge market opportunity for any company" that can reduce the cost of biosimilars within the biopharmaceutical
market," says Mordor Intelligence's new report, "Global Biopharmaceuticals
Market Growth, Trends & Forecasts (2017-2022)."
Since its introduction a year ago, the GlycoWorks RapiFIuor-MS N-Glycan Kit has saved biopharmaceutical
laboratories approximately 3.9 years of work in just its first year of availability.
WASHINGTON -- The biopharmaceutical
industry supported nearly 854,000 direct jobs and more than $1.2 trillion in economic output in the United States in 2014, according to research prepared for the Pharmaceutical Research and Manufacturers of America (PhRMA) by TEConomy Partners LLC.